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Abstract Diseases caused by viruses especially by white spot
syndrome virus (WSSV) are the greatest challenge to worldwide
shrimp aquaculture. The innate immunity of shrimp has at-
tracted extensive attention, but no factor involved in the virus
resistance has been reported. Here we report for the ¢rst time
the identi¢cation of an antiviral gene from shrimp Penaeus
monodon. A di¡erential cDNA (designated as PmAV) cloned
from virus-resistant shrimp P. monodon by di¡erential display
(DD) was found to have an open reading frame (ORF) encoding
a 170 amino acid peptide with a C-type lectin-like domain
(CTLD). The PmAV gene was expressed in Escherichia coli
and the protein was puri¢ed. Recombinant PmAV protein dis-
played a strong antiviral activity in inhibiting virus-induced cy-
topathic e¡ect in ¢sh cell in vitro. Moreover, native PmAV
protein was isolated from shrimp hemolymph by immuno-a⁄nity
chromatography and con¢rmed by Western blot. No agglutina-
tion activity was observed both in recombinant and native
PmAV protein. Immunohistological study showed that PmAV
protein was located mainly in the cytoplasm, and not bound to
the shrimp WSSV. It implies that the antiviral mechanism of
PmAV protein is not by inhibiting the attachment of virus to
target host cell. The discovery of PmAV gene might provide a
clue to elucidate the innate immunity of marine invertebrates
and would be helpful to shrimp viral disease control.
4 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Shrimp is one of the most important species in aquaculture.
During the last decade, the worldwide shrimp culture was
greatly puzzled by diseases caused by viruses particularly by
white spot syndrome virus (WSSV) and su¡ered signi¢cant
economic losses [1,2]. Due to the extreme virulence of
WSSV and a wide host range covering almost all crustaceans
[3,4], it is di⁄cult to prevent and inhibit the spread of the
virus. People also noticed that although most of the WSSV-
infected shrimps died, a few of them still survived [2]. There-
fore it is interesting to ¢nd out the immune factors responsible
for the shrimp resistance against WSSV. Like other inverte-
brates, shrimp lacks speci¢c immunity, and its disease resis-
tance relies on its innate defense system including a series of
humoral and cellular immune factors [5], so it is regarded as
an appropriate species for studying the innate immunity.
Nowadays it becomes clear that the innate immune system
plays an important role in host defense reaction [6].
In recent years, some exciting progresses at the molecular
level were made on shrimp innate immunity, such as proPO
activating system [7^9] and antimicrobial peptides [10^12].
However, they all aimed at bacteria, fungi or parasites rather
than viruses. Previous studies showed the existence of non-
protein antiviral substance in crustaceans [13], but so far little
is known about the possible innate antiviral factor generated
by the interaction between host cell and virus, and neither
antiviral gene nor antiviral protein has been characterized
from crustaceans.
In this paper, mRNA di¡erential display (DD) technique
[14] was adopted to compare the virus-sensitive and virus-re-
sistant shrimps Penaeus monodon and the ¢rst shrimp antiviral
gene PmAV was identi¢ed. The PmAV protein might play an
important role in the defense mechanism against viruses.
2. Materials and methods
2.1. Shrimps
Normal (virus-sensitive) and virus-resistant shrimps P. monodon
were collected from shrimp ponds in Longhai, Fujian, China. We
found in a pond while most shrimps died in the outbreak of WSSV,
there were still a few shrimps that survived. The activities of immune
factors, such as phenoloxidase (PO) [15], lysozyme [16], hemolysin [17]
and hemagglutinin [18], were evidently higher in these survived
shrimps than those in normal shrimps (data not shown), therefore
they were considered as virus-resistant shrimps. Shrimps in the neigh-
bor pond, which were originated from the same group of larvae,
normally grew up under the same culture conditions but were not
infected by virus, were collected as normal shrimps. WSSV was not
found by polymerase chain reaction (PCR) [19] in both normal and
virus-resistant shrimps. Live shrimps were immediately frozen in liq-
uid nitrogen and stored at 370‡C after collection.
2.2. Fluorescent DD of normal and virus-resistant shrimps
Total RNA was isolated respectively from hepatopancreases of two
kinds of shrimps mentioned above by the acid guanidine-phenol-chlo-
roform (AGPC) method [20], and then treated by DNase I (Strata-
gene). Reverse transcription (RT) and DD-PCR were performed in
duplicate by FluoroDD Kit (Beckman-Coulter) as described in the
manufacturer’s manual. Superscript II enzyme (Gibco-BRL) was
used for RT. GenomyxLRS instrument (Beckman-Coulter) was used
for electrophoresis, £uorescence scanning and band analysis.
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2.3. Northern blot and sequence analysis of di¡erential cDNA
Di¡erential cDNA band was recovered from gel, then reampli¢ed
and labeled by digoxin (Dig). Total RNA (15 Wg) from hepatopan-
creases of two kinds of shrimps were dotted respectively on positive-
charged nylon membrane (Boehringer Mannheim), and hybridized to
the Dig-labeled probe. Dig-labeling, hybridization and detection were
preformed using the kit from Boehringer Mannheim. Di¡erential
cDNA was sequenced, and then analyzed by BLAST on NCBI web-
site.
2.4. cDNA library screening
After the isolation of hepatopancreas mRNA from virus-resistant
shrimp by PolyATtract System1000 kit (Promega), a cDNA library
was constructed using V ZAP Express cDNA synthesis and Gigapack-
III Gold cloning kit (Stratagene) according to the manufacturer’s
protocol. Subsequently the library was screened with Dig-labeled
probe. Positive plaques were picked out, and then converted into
phagemids by in vivo excision as described in the manual. Relatively
long inserted fragments from several selected phagemids were se-
quenced.
2.5. Recombinant expression of PmAV cDNA, protein puri¢cation
and refolding
An open reading frame (ORF) of PmAV cDNA was ampli¢ed from
library with 5P primer TAGTGCATGCATATGCGTCATACAATCC-
TA and 3P primer CTGTCTCGAGCTATGTGTCCTGCTTTCACA.
SphI and XhoI sites were involved in the two primers, respectively (as
shown in italic letters). The PCR fragment was inserted into the thio-
redoxin-fused expression vector pThioHisC (Invitrogen). For the con-
venience of protein puri¢cation by metal (Ni) a⁄nity chromatogra-
phy, this vector was modi¢ed with six times histidine ahead of the
stop codon. Recombinant plasmid was transformed into Escherichia
coli XL1-Blue (Stratagene), and con¢rmed by sequencing. The ex-
pressed product was detected by sodium dodecyl sulfate^polyacryl-
amide gel electrophoresis (SDS^PAGE).
The PmAV protein that appeared in inclusion body was puri¢ed
with Ni-nitrilotriacetic acid (NTA) agarose (Qiagen) under denaturing
(8 M urea) conditions as described by the manufacturer. Puri¢ed
protein was refolded by gradient dialysis (urea concentration in the
sample was reduced step by step, from 8 to 0 M). The induced control
protein (named as TH) from the vector pThioHisC only was also
puri¢ed with Ni-NTA agarose under native conditions.
2.6. Antiviral assays of the PmAV protein
The antiviral activity of the recombinant PmAV protein was moni-
tored by the inhibition of SGIV (grouper iridovirus, originally isolated
from diseased brown-spotted grouper E. tauvina [21])-induced cyto-
pathic e¡ect (CPE) in GP cells (grouper embryo cells from E. tauvina).
Cells were seeded in 96-well plates at 105 cells/well in Eagle’s mini-
mum essential medium (EMEM) containing 10% fetal bovine serum,
0.116 M NaCl, 100 IU/ml penicillin and 100 Wg/ml streptomycin and
incubated at 25‡C [21]. After serial dilution, 10 Wl of various concen-
trations of the PmAV protein or TH protein were mixed with equal
volumes of virus at a multiplicity of infection (MOI, the average
number of virus particles that infect a single cell) of 0.02. When the
cells were con£uent, the cell monolayers were infected with the mix-
tures of protein and virus, or virus only as control. After a 30 min
adsorption period, the media were added, and the plates were incu-
bated at 25‡C. Each treatment was repeated four times. When the
control culture showed complete destruction (usually 3 days after
virus inoculation), the number of viable cells was determined by stain-
ing of the cells with 1% crystal violet in ethanol [22]. Following the
2^3 min staining period, excess dye was removed by washing the cell
monolayer three times with phosphate-bu¡ered saline (PBS). The con-
centration of the PmAV protein required to inhibit virus-induced CPE
to 50% of the virus-infected control (without the PmAV protein) was
estimated as the 50% e¡ective concentration (EC50) [22,23].
Cytotoxicity of the PmAV protein was evaluated as CC50 [22,23],
which corresponds to the concentration required to reduce the viable
cells to 50% of the control (without the PmAV protein). When seeded
cells were con£uent, the media were replaced by the media containing
di¡erent concentrations of the PmAV protein. 7 days later, the num-
ber of viable cells was determined by staining of the cells with 1%
crystal violet in ethanol.
2.7. Immuno-a⁄nity chromatography and Western blot
Antibody against the recombinant PmAV protein was prepared by
immunizing mouse according to the conventional method [24]. IgG
was isolated from the antiserum by protein A Sepharose (Pharmacia),
and then titered by enzyme-linked immunosorbent assay (ELISA) to
determine the optimal working concentration. IgG was coupled to
CNBr-activated Sepharose 4B (Pharmacia) to prepare the antibody
a⁄nity column as described by the manufacturer, then the column
was equilibrated with 50 mM Tris^HCl (pH 8) containing 100 mM
NaCl. Serum from healthy shrimps was loaded, and then the column
was washed with enough 50 mM Tris^HCl (pH 8) containing 100 mM
NaCl and eluted with 0.1 M glycine (pH 3).
The eluate was analyzed by 14% SDS^PAGE, and then Western
blot was performed with mouse anti-PmAV IgG according to the
conventional method [24]. Goat anti-mouse IgG alkaline phosphatase
conjugate (Promega) was used as the secondary antibody.
2.8. Immunohistological analysis
Healthy shrimps P. monodon were infected with WSSV as described
[25]. At various stages postinfection (0, 2, 6, 12, 24, and 48 h), four
specimens were selected at random. Their hepatopancreases were im-
mediately ¢xed in formaldehyde/glutaraldehyde solution. Samples
were embedded at low temperature in Lowicryl K4M resin (Polyscien-
ces), followed by sectioning (LKB-5 ultramicrotome) and immunore-
action with 10 nm gold-labeled goat anti-mouse IgG (Academy of
Military Medical Sciences of China). Finally sections were double-
stained and observed under an electron microscope (JEOL-CX100)
at 100 kV.
2.9. Virus a⁄nity chromatography
Intact WSSV viruses were puri¢ed from infected cray¢sh Cambarus
clarkia (Xiamen, China) as described [26]. Virus samples were exam-
ined under electron microscope for purity. WSSV were coupled to
CNBr-activated Sepharose 4B as above. The WSSV-coupled column
was equilibrated with 0.1 M Tris^HCl (pH 8.0). Then recombinant
PmAV protein was loaded. After washing with 10 times of bed vol-
umes of 0.1 M Tris^HCl (pH 8.0), the column was eluted with elution
bu¡er (0.1 M Tris^HCl, 1 M NaCl, pH 8.0).
Fig. 1. A fraction of £uorescence scanning picture of DD-PCR
products. PCR fragments were separated on a 5.6% high-resolution
polyacrylamide gel under denaturing (urea) conditions. DD-PCR
was carried out in duplicate. Lanes 1 and 2, DD-PCR products
from normal shrimp; lanes 3 and 4, DD-PCR products from virus-
resistant shrimp. The arrows indicate the di¡erential bands, from
which DDB was selected for further study in this paper.
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3. Results
3.1. Fluorescent DD of normal and virus-resistant shrimp
After the electrophoresis and scanning of DD-PCR prod-
ucts, some di¡erential bands between normal and virus-resis-
tant shrimps were found (Fig. 1), but only parts of them were
con¢rmed to be di¡erentially expressed cDNA by Northern
blot. BLAST analysis of sequences revealed that one of them
(named as DDB, about 450 bp) was a possible virus resis-
tance-related cDNA, therefore DDB was selected for further
study. By Northern blot with Dig-DDB probe, hepatopancre-
as total RNA from virus-resistant shrimp displayed an obvi-
ously stronger signal than that from normal shrimp, showing
that expression of DDB was upregulated in virus-resistant
shrimp.
3.2. cDNA library screening and sequence analysis
Some positive plaques were obtained by screening the he-
patopancreas cDNA library of virus-resistant shrimp with
Dig-DDB probe. The whole cDNAs were sequenced. One of
them contained an ORF (510 bp) encoding a 170 amino acid
peptide with predicted molecular weight of 19.3 kDa. The
peptide encoded by the cDNA (termed as PmAV) had no
homologous sequence after searching in GenBank with
BLAST. A C-type lectin-like domain (CTLD) was found
and no signal peptide coding sequence existed (Fig. 2).
3.3. Expression of PmAV gene in E. coli
PmAV gene was inserted into vector pThioHisC and ex-
pressed (Fig. 3, lane 3). The PmAV protein in inclusion
body was puri¢ed with Ni-NTA agarose under denaturing
conditions. The purity was estimated to be higher than 95%
(Fig. 3, lane 4). After refolding by gradient dialysis, almost all
the puri¢ed PmAV protein became soluble (Fig. 3, lane 5).
3.4. Antiviral assay of recombinant PmAV protein
As there is no suitable shrimp cell line for the function
study of shrimp gene [27,28], ¢sh cell (GP cell) was used in
this investigation. After 3 days of virus inoculation, GP cells
(Fig. 4A) were completely destructed by SGIV for virus only
(Fig. 4B) as well as the mixture of SGIV and control protein
Fig. 2. Sequences of PmAV cDNA (863 bp) and deduced peptide (170 amino acids). Predicted ORF is from 88 to 597 bp (the start and stop
codons are shown in bold). The di¡erential fragment obtained by DD is from 447 to 863 bp. CTLD is located at the region from 33 to 166
amino acids.
Fig. 3. 14% SDS^PAGE analysis of recombinant expressed and pu-
ri¢ed protein encoded by PmAV gene. Proteins were stained with
Coomassie blue R-250. Lane M, low molecular weight marker
(Pharmacia); lane 1, pThioHisC-XL1-Blue, isopropyl thiogalactose
(IPTG)-induced; lane 2, pThioHisC-PmAV-XL1-Blue, non-induced;
lane 3, pThioHis-PmAV-XL1-Blue, IPTG-induced for 4 h; lane 4,
a⁄nity-puri¢ed recombinant PmAV protein; lane 5, refolded re-
combinant PmAV protein; lane 6, a⁄nity-puri¢ed control protein
TH.
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TH (Fig. 4C), while approximately 50% GP cells incubated
with the mixture of SGIV and PmAV protein remained viable
(Fig. 4D). EC50 was determined to be approximately 6.25 Wg/
ml. It was convinced that PmAV protein had non-speci¢c
antiviral activity.
On the other hand, the cytotoxicity of PmAV protein to the
GP cell, evaluated as CC50, was more than 200 Wg/ml (data
not shown), suggesting that PmAV protein had no cytotox-
icity to tested cells.
3.5. Isolation of the native PmAV protein
An approximate 28 kDa protein was isolated from shrimp
serum by immuno-a⁄nity chromatography (Fig. 5A). The
same result was obtained by Western blot with the anti-
PmAV IgG (Fig. 5B), suggesting that this 28 kDa protein
should be the native PmAV protein in shrimp P. monodon.
Nevertheless, we have described previously that PmAV cDNA
encodes a 170 amino acid peptide with a predicted molecular
weight of 19.3 kDa, obviously there is a disagreement in mo-
lecular mass between the deduced peptide and native protein.
Sequence analysis of the deduced peptide predicted that the
protein may contain sites for phosphorylation, glycosylation
and alkylation. This type of discrepancy between the calcu-
lated molecular mass and the apparent molecular mass on an
SDS gel is quite common among proteins that are heavily
modi¢ed.
3.6. Immunohistological analysis and virus a⁄nity
chromatography
Many gold particles were observed in the cytoplasm of he-
patopancreas at 12 and 24 h postinfection with WSSV, but
not in the organelles, the cell nucleus and extracellular matrix
(Fig. 6A). WSSV was found in the nucleus at 24 h postinfec-
tion, but no gold particles were observed on or near WSSV
(Fig. 6B). This result suggested that the PmAV protein didn’t
directly interact with virus when it performed the antiviral
function.
Even detected by silver staining, PmAV protein was found
£owing through the virus-coupled column without binding to
WSSV.
4. Discussion
Virus infections are common among invertebrates, but little
is known about the ability of invertebrates to deal with viral
infections. So it is essential to study the virus-related genes
and their functions involved in the innate immunity and dis-
ease resistance of invertebrates. Although the shrimp genome
project is unable to be launched entirely now, a number of
sequences of shrimp genes were determined by various meth-
ods [29^31]. Some of them were supposed to be immunity-
related, but it is di⁄cult to con¢rm their functions due to lack
of shrimp cell culture system. So far, the immune mechanism
of shrimp is not clear yet.
In this report, we cloned, expressed and identi¢ed an anti-
viral gene PmAV from shrimp P. monodon for the ¢rst time.
Fig. 4. Antiviral assay of recombinant PmAV protein. A: Normal GP cells. B: GP cells after 3 days of incubation with SGIV only. C: GP
cells after 3 days of incubation with the mixture of SGIV and control protein TH (6.25 Wg/ml). D: GP cells after 3 days of incubation with the
mixture of SGIV and PmAV protein (6.25 Wg/ml).
Fig. 5. Isolation and Western blot of the native PmAV protein.
A: 14% SDS^PAGE of the eluate from antibody a⁄nity column,
silver staining. B: Western blot of the eluate.
Fig. 6. Immunohistological analysis of the PmAV protein in shrimp
hepatopancreas. A: The cytoplasm (24 h postinfection with WSSV,
40 ,000U), arrows indicating gold particles. B: WSSV in the nu-
cleus, no gold particle (24 h postinfection, 20 000U)
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The PmAV protein contains a CTLD. As we know, C-type
animal lectin exists widely in vertebrates and invertebrates,
and it represents an important recognition mechanism for ol-
igosaccharides at cell surfaces [32]. All C-type lectins contain a
carbohydrate recognition domain (CRD) which mediates sug-
ar binding with Ca2þ [33]. Currently more than 100 human
proteins containing CTLDs have been reported, and among
them approximately half were supposed to function as C-type
CRDs. Many CTLDs bind to protein ligands rather than
sugars, and only some of these binding interactions are
Ca2þ-dependent [34]. They are considered to be developed
from original CTLDs by divergent evolution. Many molecules
containing CTLD are related to immunity, such as C-type
lectin, coagulation factor binding protein, IgE Fc receptor
and NK cell receptor [32].
Our results showed that neither recombinant PmAV protein
nor native PmAV protein had agglutination activity (data not
shown), suggesting that PmAV doesn’t encode a lectin. Since
the PmAV protein has antiviral activity, does its CTLD rec-
ognize and bind to shrimp virus? As no gold particle adhered
to WSSV in immunohistological observation, and no PmAV
protein bound to WSSV when £owing through the virus af-
¢nity column, we assumed that the PmAV protein might act
as an intermediate rather than a recognition factor during the
antiviral reaction. Further works are needed to reveal the
antiviral mechanism of PmAV in detail.
So far, neither antiviral gene nor antiviral protein from
shrimp was reported, and almost all studies on molecular
biology of innate immunity of shrimps aimed at bacteria,
fungi, parasites, etc. The PmAV gene is the ¢rst antiviral
gene from shrimp reported, and it might be an important
innate host defense factor. It would provide us a clue to elu-
cidate the innate immunity and to control diseases of marine
invertebrates.
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